Metformin: The Cheap Pill That Mimics Exercise Benefits

Study finds diabetes drug metformin may provide metabolic boost without physical activity

Apr. 11, 2026 at 12:03pm

Got story updates? Submit your updates here. ›

A ghostly, translucent X-ray image of a human hand, revealing the intricate bone structure and veins in a glowing, ethereal manner against a dark background, conceptually representing the potential of metformin to mimic the metabolic effects of exercise.The study's findings suggest metformin could provide metabolic benefits without the need for physical exertion, offering new hope for cancer patients and others struggling with limited mobility.Today in Miami

Researchers at the University of Miami Miller School of Medicine have discovered that the common diabetes drug metformin can mimic the effects of intense exercise, even in individuals who lead a sedentary lifestyle. The study, published in EMBO Molecular Medicine, examined the impact of metformin on N-lactoyl-phenylalanine (Lac-Phe), a molecule released during exercise, in men with prostate cancer. The findings suggest metformin could potentially offer a range of health benefits, particularly for cancer patients who struggle with fatigue and limited physical activity.

Why it matters

This discovery is significant as it suggests metformin could provide metabolic benefits without the need for physical exertion, which is especially important for cancer patients who often experience fatigue and struggle to engage in physical activity. The findings highlight the broader implications of metformin's potential, as it could influence how cancer care is approached by supporting metabolic health in addition to targeting tumors.

The details

The study, led by Dr. Marijo Bilusic, a medical oncologist, examined the impact of metformin on Lac-Phe levels in 29 men diagnosed with prostate cancer. Lac-Phe is known to spike after intense physical activity and has been linked to appetite suppression and weight loss. The researchers found that metformin raised Lac-Phe levels in the patients, suggesting the drug could potentially mimic some of the benefits of exercise, even in those who are inactive.

  • The study was published in the journal EMBO Molecular Medicine in 2026.

The players

Dr. Marijo Bilusic

A medical oncologist and lead author of the study at the University of Miami Miller School of Medicine.

David Lombard

A Sylvester researcher and professor of pathology and laboratory medicine at the Miller School, who noted that metabolism is involved in everything cells do.

Priyamvada Rai

A professor of radiation oncology at the Miller School, who suggested that cancer care should focus on supporting metabolic health in addition to targeting tumors.

Got photos? Submit your photos here. ›

What they’re saying

“From a clinical standpoint, seeing a metabolic signal that mirrors what we associate with intense exercise was striking. For patients whose treatments or symptoms limit physical activity, that kind of effect could be especially meaningful.”

— Dr. Marijo Bilusic, Medical oncologist and lead author of the study

“Supporting metabolic health can influence how patients tolerate treatment and how they feel over time, even if it doesn't directly change tumor growth. This study was an opportunity to investigate molecular pathways that can be therapeutically activated for better outcomes to treatments that induce metabolic stress.”

— Priyamvada Rai, Professor of radiation oncology

What’s next

The research team plans to further investigate the potential of metformin to support metabolic health in cancer patients, particularly those who struggle with fatigue and limited physical activity.

The takeaway

This study highlights the importance of exploring the metabolic pathways that can be therapeutically activated to improve outcomes in cancer care, beyond just targeting the tumor. The discovery that a common and inexpensive drug like metformin can mimic the benefits of exercise opens up new avenues for supporting the overall well-being of cancer patients.